Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Ajinomoto, Sankyo Announce Agreement on Novel Diabetes Treatment
September 11, 2006
- DNA Chip Research Focuses on Chips for Prediction of Prognosis, Preoperative Diagnosis
September 11, 2006
- Korosho Drafting New Vision for the Pharmaceutical Industry
September 11, 2006
- Unapproved CO Monitor Recalled
September 11, 2006
- BUSINESS NEWS IN BRIEF
September 11, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 11, 2006
- SELF-MEDICATION NEWS IN BRIEF
September 11, 2006
- JPA Survey Shows Strong Impact of TV Commercials on Use of Generics
September 11, 2006
- Korosho's FY2007 Budget Request Totals \21.6 Trillion with Focus on Anti-Cancer Measures
September 11, 2006
- Medical Expenditure Rose 1.8% to \32.1 Tril. in FY2004
September 11, 2006
- METI's Draft Budget Request Earmarks \2.8 Bil. for Anticancer Measures
September 11, 2006
- Working Team Proposes 5 New Targets for Healthy Japan 21 Project
September 11, 2006
- CDFS Committee Recommends Approval of 4 Drugs Including Velcade
September 11, 2006
- Weight of Healthcare Business Continues to Increase at Philips
September 11, 2006
- Group to Review Reports on Drugs for Pediatric Use
September 11, 2006
- Korosho Considers Prescription Surveys for Pediatric Use of Drugs
September 11, 2006
- 164 Facilities to Collect Prescription Data on Pediatric Drug Use
September 11, 2006
- Korosho Summons Wholesalers Again - Price Agreement Rates Remain Low
September 11, 2006
- Switchover to Marketing Business License to Peak in FY2006
September 11, 2006
- REGULATORY NEWS IN BRIEF
September 11, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…